As a civilian partner working for the Army for many years following his time in Vietnam, Jim didn’t suspect anything was amiss when he went for his annual health exam in 2006. However, during...

Astellas, through its Mitobridge affiliate, has dosed the first patient in its pivotal Phase 2/3 clinical trial for ASP0367*, an oral investigational drug that may improve exercise intolerance and...

This is an older article. For fresher news about Astellas Onc, click here. In Chicago, more than 40,000 people from around the world involved in cancer research gathered to learn about the latest...

Winners of the Astellas Oncology C3 (Changing Cancer Care) Prize are actively working to transform what it means to live with a cancer diagnosis and improve the patient experience throughout the...

Oct 16, 2019 In an effort to address and help improve the existing standard of care for men newly diagnosed with prostate cancer, Astellas and Pack Health, a digital health coaching company that...

By Mark Reisenauer, Senior Vice President, Oncology Business Unit Sep 3, 2019 As we enter September and the changing of the seasons, let’s remember a group out there that needs our support....

Aug 7, 2019 Astellas seeks external collaborations to help deepen patient insights and add value to the patient journey Those suffering with chronic medical conditions, of which eighty percent of...

Astellas Executive Interview Series – Alison Hayles Executive Director of Global Regulatory Affairs, Oncology Therapeutic Area Development Head After moving to the United States in 2001, Alison...

By Pete Sandor, Vice President, Global Oncology Feb 4, 2019 Today marks the 19th annual recognition of World Cancer Day. This provides an opportunity to reflect on the progress in improving cancer...

At Astellas, we are dedicated to supporting and improving the lives of those impacted by cancer. One of the ways we provide this support is by working with patient advocacy organizations, such as...